ChemoCentryx Financial Statements (CCXI)
|
|
|
|
Report date
|
|
|
31.12.2025 |
|
31.03.2026 |
|
Currency
|
|
|
USD |
|
USD |
|
|
Revenue, bln rub |
? |
|
0.000 |
|
0.000 |
|
Operating Income, bln rub |
|
|
-0.168 |
|
-0.126 |
|
EBITDA, bln rub |
? |
|
-0.168 |
|
-0.126 |
|
Net profit, bln rub |
? |
|
0.382 |
|
0.514 |
|
|
OCF, bln rub |
? |
|
-0.633 |
|
-0.633 |
|
CAPEX, bln rub |
? |
|
0.000 |
|
0.000 |
|
FCF, bln rub |
? |
|
-0.633 |
|
-0.633 |
|
Dividend payout, bln rub
|
|
|
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
|
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
|
0.00% |
|
|
OPEX, bln rub |
|
|
0.168 |
|
0.126 |
|
Cost of production, bln rub |
|
|
0.000 |
|
0.000 |
|
R&D, bln rub |
|
|
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
415.9 |
|
10.3 |
|
Net Assets, bln rub |
? |
|
399.8 |
|
9.91 |
|
Debt, bln rub |
|
|
0.000 |
|
0.000 |
|
Cash, bln rub |
|
|
0.736 |
|
0.010 |
|
Net debt, bln rub |
|
|
-0.74 |
|
-0.01 |
|
|
Ordinary share price, rub |
|
|
|
|
10.2 |
|
Number of ordinary shares, mln |
|
|
55.7 |
|
55.7 |
|
|
Market cap, bln rub |
|
|
0 |
|
566 |
|
EV, bln rub |
? |
|
-1 |
|
566 |
|
Book value, bln rub |
|
|
400 |
|
10 |
|
|
EPS, rub |
? |
|
0.01 |
|
0.01 |
|
FCF/share, rub |
|
|
-0.01 |
|
-0.01 |
|
BV/share, rub |
|
|
7.18 |
|
0.18 |
|
|
FCF yield, % |
? |
|
|
|
-0.11% |
|
ROE, % |
? |
|
0.10% |
|
5.19% |
|
ROA, % |
? |
|
0.09% |
|
4.99% |
|
|
P/E |
? |
|
0.00 |
|
1 101 |
|
P/FCF |
|
|
0.00 |
|
-894.2 |
|
P/BV |
? |
|
0.00 |
|
57.1 |
|
EV/EBITDA |
? |
|
4.39 |
|
-4 480 |
|
Debt/EBITDA |
|
|
4.39 |
|
0.08 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
|
0.00% |
|
| ChemoCentryx shareholders |
